Phosphodiesterase 8B Gene Variants Are Associated with Serum TSH Levels and Thyroid Function

American Journal of Human Genetics

Volumn 82, Issue 6, 2008, Pages 1270-1280

  Arnaud Lopez, Lisette ^a   Usala, Gianluca ^b   Ceresini, Graziano ^c   Mitchell, Braxton D ^d   Pilia, Maria Grazia ^b   Piras, Maria Grazia ^b   Sestu, Natascia ^b   Maschio, Andrea ^b   Busonero, Fabio ^b   Albai, Giuseppe ^b   Dei, Mariano ^b   Lai, Sandra ^b   Mulas, Antonella ^b   Crisponi, Laura ^b   Tanaka, Toshiko ^a   Bandinelli, Stefania ^e   Guralnik, Jack M ^a   Loi, Angela ^b   Balaci, Lenuta ^b   Sole, Gabriella ^b   Prinzis, Alessia ^f   Mariotti, Stefano ^f   Shuldiner, Alan R ^d,g   Cao, Antonio ^b   Schlessinger, David ^a   Uda, Manuela ^b   Abecasis, Gonçalo R ^h   Nagaraja, Ramaiah ^a   Sanna, Serena ^b   Naitza, Silvia ^b   more..

^a NATIONAL INSTITUTE ON AGING   (United States)

^b CNR   (Italy)

^c UNIVERSITY OF PARMA   (Italy)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^e Azienda Sanitaria di Firenze   (Italy)

^f UNIVERSITY OF CAGLIARI   (Italy)

^g BALTIMORE VA MEDICAL CENTER   (United States)

^h UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; PHOSPHODIESTERASE; THYROTROPIN;

ADOLESCENT; ADULT; AGED; ARTICLE; FEMALE; GENE; GENETIC ANALYSIS; GENETIC VARIABILITY; GENOME; GENOTYPE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; PHOSPHODIESTERASE 8B GENE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; THYROID FUNCTION; THYROTROPIN BLOOD LEVEL;

3',5'-CYCLIC-AMP PHOSPHODIESTERASES; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHROMOSOME MAPPING; CYCLIC AMP; FEEDBACK; FEMALE; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; PITUITARY GLAND; POLYMORPHISM, SINGLE NUCLEOTIDE; THYROID DISEASES; THYROID GLAND; THYROTROPIN; THYROXINE; TRIIODOTHYRONINE; VARIATION (GENETICS);

EID: 44449164338     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajhg.2008.04.019     Document Type: Article

References (47)

1. Kopp P. Thyroid hormone synthesis. In: Braverman L.E., and Utiger R.D. (Eds). The Thyroid. A Fundamental and Clinical Text (2005), Lippincott, New York 52-76
2. Yen P.M. Physiological and molecular basis of thyroid hormone action. Physiol. Rev. 81 (2001) 1097-1142
3. Vassart G., and Dumont J.E. The thyrotropin receptor and the regulation of thyrocyte function and growth. Endocr. Rev. 13 (1992) 596-611
4. Dahl G.E., Evans N.P., Thrun L.A., and Karsch F.J. A central negative feedback action of thyroid hormones on thyrotropin-releasing hormone secretion. Endocrinology 135 (1994) 2392-2397
5. Barnett P. Somatostatin and somatostatin receptor physiology. Endocrine 20 (2003) 255-264
6. Larsen P.R. Thyroid-pituitary interaction: Feedback regulation of thyrotropin secretion by thyroid hormones. N. Engl. J. Med. 306 (1982) 23-32
7. Pilia G., Chen W.M., Scuteri A., Orru M., Albai G., Dei M., Lai S., Usala G., Lai M., Loi P., et al. Heritability of cardiovascular and personality traits in 6,148 Sardinians. PLoS Genet. 2 (2006) e132
8. Andersen S., Pedersen K.M., Bruun N.H., and Laurberg P. Narrow individual variations in serum T(4) and T(3) in normal subjects: A clue to the understanding of subclinical thyroid disease. J. Clin. Endocrinol. Metab. 87 (2002) 1068-1072
9. Allen E.M., Hsueh W.C., Sabra M.M., Pollin T.I., Ladenson P.W., Silver K.D., Mitchell B.D., and Shuldiner A.R. A genome-wide scan for autoimmune thyroiditis in the Old Order Amish: Replication of genetic linkage on chromosome 5q11.2-q14.3. J. Clin. Endocrinol. Metab. 88 (2003) 1292-1296
10. Balaci L., Spada M.C., Olla N., Sole G., Loddo L., Anedda F., Naitza S., Zuncheddu M.A., Maschio A., Altea D., et al. IRAK-M is involved in the pathogenesis of early-onset persistent asthma. Am. J. Hum. Genet. 80 (2007) 1103-1114
11. Scuteri A., Sanna S., Chen W.M., Uda M., Albai G., Strait J., Najjar S., Nagaraja R., Orru M., Usala G., et al. Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity-related traits. PLoS Genet. 3 (2007) e115
12. Li S., Sanna S., Maschio A., Busonero F., Usala G., Mulas A., Lai S., Dei M., Orru M., Albai G., et al. The GLUT9 gene is associated with serum uric acid levels in Sardinia and Chianti cohorts. PLoS Genet. 3 (2007) e194
13. Willer C.J., Sanna S., Jackson A.U., Scuteri A., Bonnycastle L.L., Clarke R., Heath S.C., Timpson N.J., Najjar S.S., Stringham H.M., et al. Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat. Genet. 40 (2008) 161-169
14. Sanna S., Jackson A.U., Nagaraja R., Willer C.J., Chen W.M., Bonnycastle L.L., Shen H., Timpson N., Lettre G., Usala G., et al. Common variants in the GDF5-UQCC region are associated with variation in human height. Nat. Genet. 40 (2008) 198-203
15. Uda M., Galanello R., Sanna S., Lettre G., Sankaran V.G., Chen W., Usala G., Busonero F., Maschio A., Albai G., et al. Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and amelioration of the phenotype of beta-thalassemia. Proc. Natl. Acad. Sci. USA 105 (2008) 1620-1625
16. Hayashi M., Matsushima K., Ohashi H., Tsunoda H., Murase S., Kawarada Y., and Tanaka T. Molecular cloning and characterization of human PDE8B, a novel thyroid-specific isozyme of 3′,5′-cyclic nucleotide phosphodiesterase. Biochem. Biophys. Res. Commun. 250 (1998) 751-756
17. Shumway-Cook A., Guralnik J.M., Phillips C.L., Coppin A.K., Ciol M.A., Bandinelli S., and Ferrucci L. Age-associated declines in complex walking task performance: The Walking InCHIANTI toolkit. J. Am. Geriatr. Soc. 55 (2007) 58-65
18. Sorkin J., Post W., Pollin T.I., O'Connell J.R., Mitchell B.D., and Shuldiner A.R. Exploring the genetics of longevity in the Old Order Amish. Mech. Ageing Dev. 126 (2005) 347-350
19. Gross-Langenhoff M., Hofbauer K., Weber J., Schultz A., and Schultz J.E. cAMP is a ligand for the tandem GAF domain of human phosphodiesterase 10 and cGMP for the tandem GAF domain of phosphodiesterase 11. J. Biol. Chem. 281 (2006) 2841-2846
20. Refetoff S., Weiss R.E., and Usala S.J. The syndromes of resistance to thyroid hormone. Endocr. Rev. 14 (1993) 348-399
21. Kero J., Ahmed K., Wettschureck N., Tunaru S., Wintermantel T., Greiner E., Schutz G., and Offermanns S. Thyrocyte-specific Gq/G11 deficiency impairs thyroid function and prevents goiter development. J. Clin. Invest. 117 (2007) 2399-2407
22. Chen W.M., and Abecasis G.R. Family-based association tests for genomewide association scans. Am. J. Hum. Genet. 81 (2007) 913-926
23. Ferrucci L., Bandinelli S., Benvenuti E., Di Iorio A., Macchi C., Harris T.B., and Guralnik J.M. Subsystems contributing to the decline in ability to walk: Bridging the gap between epidemiology and geriatric practice in the InCHIANTI study. J. Am. Geriatr. Soc. 48 (2000) 1618-1625
24. Mitchell B.D., McArdle P.F., Shen H., Rampersaud E., Pollin T.I., Bielak L.F., Jaquish C., Douglas J.A., Roy-Gagnon M.H., Sack P., et al. The genetic response to short-term interventions affecting cardiovascular function: Rationale and design of the Heredity and Phenotype Intervention (HAPI) Heart Study. Am. Heart J. 155 (2008) 823-828
25. Lander E.S., and Green P. Construction of multilocus genetic linkage maps in humans. Proc. Natl. Acad. Sci. USA 84 (1987) 2363-2367
26. Abecasis G.R., Cherny S.S., Cookson W.O., and Cardon L.R. Merlin-rapid analysis of dense genetic maps using sparse gene flow trees. Nat. Genet. 30 (2002) 97-101
27. Benjamini Y., and Hochberg Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J.R. Stat. Soc. Ser. D Stat. Methodol. 57 (1995) 289-300
28. Almasy L., and Blangero J. Multipoint quantitative-trait linkage analysis in general pedigrees. Am. J. Hum. Genet. 62 (1998) 1198-1211
29. Damcott C.M., Ott S.H., Pollin T.I., Reinhart L.J., Wang J., O'Connell J.R., Mitchell B.D., and Shuldiner A.R. Genetic variation in adiponectin receptor 1 and adiponectin receptor 2 is associated with type 2 diabetes in the Old Order Amish. Diabetes 54 (2005) 2245-2250
30. Abecasis G.R., and Cookson W.O. GOLD-graphical overview of linkage disequilibrium. Bioinformatics 16 (2000) 182-183
31. International HapMap Consortium. A haplotype map of the human genome. Nature 437 (2005) 1299-1320
32. Higgins J.P.T., and Thompson S.G. Quantifying heterogeneity in a meta-analysis. Stat. Med. 21 (2002) 1539-1558
33. Jacobson E.M., and Tomer Y. The genetic basis of thyroid autoimmunity. Thyroid 17 (2007) 949-961
34. Persani L., Lania A., Alberti L., Romoli R., Mantovani G., Filetti S., Spada A., and Conti M. Induction of specific phosphodiesterase isoforms by constitutive activation of the cAMP pathway in autonomous thyroid adenomas. J. Clin. Endocrinol. Metab. 85 (2000) 2872-2878
35. Oki N., Takahashi S.I., Hidaka H., and Conti M. Short term feedback regulation of cAMP in FRTL-5 thyroid cells. Role of PDE4D3 phosphodiesterase activation. J. Biol. Chem. 275 (2000) 10831-10837
36. Hetman J.M., Soderling S.H., Glavas N.A., and Beavo J.A. Cloning and characterization of PDE7B, a cAMP-specific phosphodiesterase. Proc. Natl. Acad. Sci. USA 97 (2000) 472-476
37. Bender A.T., and Beavo J.A. Cyclic nucleotide phosphodiesterases: Molecular regulation to clinical use. Pharmacol. Rev. 58 (2006) 488-520
38. Hayashi M., Shimada Y., Nishimura Y., Hama T., and Tanaka T. Genomic organization, chromosomal localization, and alternative splicing of the human phosphodiesterase 8B gene. Biochem. Biophys. Res. Commun. 297 (2002) 1253-1258
39. Persani L., Borgato S., Lania A., Filopanti M., Mantovani G., Conti M., and Spada A. Relevant cAMP-specific phosphodiesterase isoforms in human pituitary: Effect of Gs(alpha) mutations. J. Clin. Endocrinol. Metab. 86 (2001) 3795-3800
40. Radovick S., Nations M., Du Y., Berg L.A., Weintraub B.D., and Wondisford F.E. A mutation in the POU-homeodomain of Pit-1 responsible for combined pituitary hormone deficiency. Science 257 (1992) 1115-1118
41. Tonacchera M., Perri A., De Marco G., Agretti P., Banco M.E., Di Cosmo C., Grasso L., Vitti P., Chiovato L., and Pinchera A. Low prevalence of thyrotropin receptor mutations in a large series of subjects with sporadic and familial nonautoimmune subclinical hypothyroidism. J. Clin. Endocrinol. Metab. 89 (2004) 5787-5793
42. Horvath A., Mericq V., and Stratakis C.A. Mutation in PDE8B, a cyclic AMP-specific phosphodiesterase in adrenal hyperplasia. N. Engl. J. Med. 358 (2008) 750-752
43. Perez-Torres S., Cortes R., Tolnay M., Probst A., Palacios J.M., and Mengod G. Alterations on phosphodiesterase type 7 and 8 isozyme mRNA expression in Alzheimer's disease brains examined by in situ hybridization. Exp. Neurol. 182 (2003) 322-334
44. Dov A., Abramovitch E., Warwar N., and Nesher R. Diminished phosphodiesterase-8B potentiates biphasic insulin response to glucose. Endocrinology 149 (2008) 741-748
45. Dousa T.P. Cyclic-3′,5′-nucleotide phosphodiesterase isozymes in cell biology and pathophysiology of the kidney. Kidney Int. 55 (1999) 29-62
46. Horvath A., Boikos S., Giatzakis C., Robinson-White A., Groussin L., Griffin K.J., Stein E., Levine E., Delimpasi G., Hsiao H.P., et al. A genome-wide scan identifies mutations in the gene encoding phosphodiesterase 11A4 (PDE11A) in individuals with adrenocortical hyperplasia. Nat. Genet. 38 (2006) 794-800
47. Dastidar S.G., Rajagopal D., and Ray A. Therapeutic benefit of PDE4 inhibitors in inflammatory diseases. Curr. Opin. Investig. Drugs 8 (2007) 364-372